KERRY ENSMINGER: Open Payments
NPI 1467668160 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 42 payments from 13 companies in 2025. Trend: 2023 $933 · 2024 $1,022 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $183 |
| Novo Nordisk Inc | 5 | $168 |
| Lilly USA, LLC | 7 | $151 |
| ABBVIE INC. | 7 | $140 |
| Abbott Laboratories | 4 | $88 |
| PFIZER INC. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| IBSA Pharma Inc. | 1 | $19 |
Products named: Ozempic, MOUNJARO, BREZTRI, FREESTYLE LIBRE 3, UBRELVY, AIRSUPRA, QULIPTA, PREVNAR 20.
Industry payments across KS — which companies pay providers there.
